The FDA approved Novavax’s COVID vaccine Nuvaxovid this month, limiting its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

Previously, updated COVID vaccines had been recommended annually by the CDC for everyone over the age of 6 months. The CDC ...

As the Trump administration moves to limit COVID booster vaccines for some, here's what to know about the latest variant NB.1 ...

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...

The FDA recommended different standards of evidence for approval based on patients' risk of getting severely sick from Covid.

In a significant shift this week, Health Secretary Robert F. Kennedy Jr. announced that COVID-19 vaccines will no longer be recommended for healthy children and pregnant individuals. That sparked ...

The FDA will now require clinical trials to approve boosters for healthy Americans under 65, making it unlikely the shots ...

On Tuesday, the Food and Drug Administration announced that Covid booster shots will be limited to people over 65 and those ...

Regulators say updated booster shots won’t be approved for healthy people under age 65 unless drugmakers conduct new trials.

Older adults can continue getting covid boosters, but not everyone who wants them can. You’re reading The Checkup With Dr.

The US FDA has approved Moderna's next-generation COVID-19 vaccine, mNEXSPIKE, for use in adults aged 65 and older.